Plasmid DNA (pDNA) is a critical raw material for the manufacture of cell and gene therapies. As this market continues to grow, so too does the demand for high-quality pDNA.
Barry J. Oliver
Advertisement
Barry J. Oliver, vice president, Quality, Catalent Cell, Gene & Protein Therapies.
Articles by Barry J. Oliver
Advertisement
Latest Updated Articles
Plasmid DNA—The Versatile Building BlockPublished: September 16th 2023 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
3
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
4
